Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation

Abstract

Besides their emerging role as markers of endothelial dysfunction SDMA and ADMA may promote endothelial injury in RA as mediators of the adverse effects of systemic inflammation on micro- and macrovasculature respectively in patients with active disease.